Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)
Go back to Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)| (NASDAQ: PTPI) | Delayed: 0.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.63 | 52 Week High | $ | |||
| Open | $0.63 | 52 Week Low | $ | |||
| Day High | $0.63 | P/E | N/A | |||
| Day Low | $0.63 | EPS | $ | |||
| Volume | 1,392 | |||||
